Capecitabine 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 0mmHg at 25℃ |
| Water Solubility | Slightly soluble |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.7 |
| B pt. | 437.874℃ at 760 mmHg |
| M pt. | 123℃(dec.) |
| Density | 1.49 g/cm3 |
Safety Information
| Hazard Statement(s) | H341 - H350 - H360FD |
| Precautionary Statement | P201 - P281 - P308 + P313 |
| Symbol |
|
| Signal word | Danger |
| HS Code | 2934999090 |
| Flash point | 218.619℃ |
| Storage Temp. | Store at 0-10℃ |
| Packaging | Glass bottle |
Description
Recommended products
5-Deoxy-5-fluoro-N4-[(pentyloxy)carbonyl]cytidine
Application
Capecitabine is an anti-cancer drug a prodrug of doxifluridine metabolized to 5-fluorouracil at the tumor site. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites 5-Deoxy-5-fluorocytidine (5-DFCR) and 5-Deoxy-5-fluorouridine (5-DFUR) to form 5-fluorouracil.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Capecitabine is an antineoplastic agent. Capecitabine is a prodrug of Doxifluridine.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |